Contact
searchSearch
HMP Global

Interactive Features

Quiz
RSV Vaccine Modalities in Phase 3 Trials for Older Adults
04/27/2023
Which of the following respiratory syncytial virus vaccine approaches are being studied in phase 3 trials for older adults?
Which of the following respiratory syncytial virus vaccine approaches are being studied in phase 3 trials for older adults?
Which of the following...
04/27/2023
First Report Managed Care
Quiz
Vaccines for Reducing the Burden of Respiratory Syncytial Virus
04/20/2023
According to a recent modeling study, approximately how many respiratory syncytial virus infections could be prevented among older adults with a vaccine that is 70% efficacious?
According to a recent modeling study, approximately how many respiratory syncytial virus infections could be prevented among older adults with a vaccine that is 70% efficacious?
According to a recent modeling...
04/20/2023
First Report Managed Care
Quiz
Phase 3 Data Reveal RSV Vaccine's Efficacy and Safety
03/31/2023
In a phase 3 trial, how efficacious was the RSVPreF3 OA vaccine for preventing severe RSV-related lower respiratory tract disease in older adults?
In a phase 3 trial, how efficacious was the RSVPreF3 OA vaccine for preventing severe RSV-related lower respiratory tract disease in older adults?
In a phase 3 trial, how...
03/31/2023
First Report Managed Care
Quiz
Respiratory Syncytial Virus Vaccines in the Pipeline for Older Adults
03/30/2023
How many vaccines for respiratory syncytial virus are in late-stage development for older adults?
How many vaccines for respiratory syncytial virus are in late-stage development for older adults?
How many vaccines for...
03/30/2023
First Report Managed Care
FDA Alerts
Dupilumab First and Only Treatment Approved for Adults with Prurigo Nodularis
09/29/2022
The US Food and Drug Administration recently announced approval of dupilumab as the first and only treatment indicated for adults with prurigo nodularis.
The US Food and Drug Administration recently announced approval of dupilumab as the first and only treatment indicated for adults with prurigo nodularis.
The US Food and Drug...
09/29/2022
The Dermatologist
FDA Alerts
Baricitinib Approved for Adult Patients With Severe Alopecia Areata
06/15/2022
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug...
06/15/2022
The Dermatologist
Quiz
Understanding CAR-T Clinical Trial Enrollment
12/14/2020
True or False: Criteria for inclusion and exclusion in clinical trials of chimeric antigen receptor T-cell therapy for hematologic malignancies are highly variable and bring to light the need for a more standardized approach to patient...
True or False: Criteria for inclusion and exclusion in clinical trials of chimeric antigen receptor T-cell therapy for hematologic malignancies are highly variable and bring to light the need for a more standardized approach to patient...
True or False: Criteria for...
12/14/2020
First Report Managed Care
Quiz
Identifying New Standard of Care for Patients With DLBCL
12/08/2020
True or False: Skipping radiation and receiving less chemotherapy may become the new standard of care.
True or False: Skipping radiation and receiving less chemotherapy may become the new standard of care.
True or False: Skipping...
12/08/2020
First Report Managed Care
Poll
Next Steps for Managed Care Professionals During COVID-19
04/03/2020
Significant change is still to come in the fight against COVID-19. First Report Managed Care would like to open the conversation between managed care professionals by providing a space to share concerns and discuss the days to come.
Significant change is still to come in the fight against COVID-19. First Report Managed Care would like to open the conversation between managed care professionals by providing a space to share concerns and discuss the days to come.
Significant change is still to...
04/03/2020
First Report Managed Care
Poll
How is COVID-19 Impacting Managed Care Markets?
03/19/2020
As COVID-19 continues to affect industries of all kinds, First Report Managed Care wants to know how managed care markets are being impacted. Please take a moment to share your experiences during the pandemic, as well as any expectations for...
As COVID-19 continues to affect industries of all kinds, First Report Managed Care wants to know how managed care markets are being impacted. Please take a moment to share your experiences during the pandemic, as well as any expectations for...
As COVID-19 continues to affect...
03/19/2020
First Report Managed Care

Behind the Bill

Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care
Behind the Bill
Medicare Drug Negotiations 2.0: New Administration, Same Mission?
01/22/2025
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
Last week brought 2 major...
01/22/2025
First Report Managed Care
Behind the Bill
The First 100 Days: Health Care's Critical Deadlines in 2025
01/15/2025
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
The 119th Congress faces...
01/15/2025
First Report Managed Care
Behind the Bill
Trump's Executive Orders in a Post-Chevron World: Implications for Health Care Policy
01/08/2025
Happy New Year! As we dive into 2025, it’s clear that this year promises to bring significant changes to health care. With President-elect Donald Trump's inauguration just weeks away, the spotlight is already shifting to how his...
Happy New Year! As we dive into 2025, it’s clear that this year promises to bring significant changes to health care. With President-elect Donald Trump's inauguration just weeks away, the spotlight is already shifting to how his...
Happy New Year! As we dive into...
01/08/2025
First Report Managed Care
Behind the Bill
A Tale of Two Congresses—Health Care Policy in the 117th vs 118th
12/18/2024
The 118th Congress is wrapping up with a whimper rather than a bang when it comes to health care legislation, particularly compared to its predecessor's transformative impact on pharmaceutical policy. As we reflect on these past 4 years, the...
The 118th Congress is wrapping up with a whimper rather than a bang when it comes to health care legislation, particularly compared to its predecessor's transformative impact on pharmaceutical policy. As we reflect on these past 4 years, the...
The 118th Congress is wrapping...
12/18/2024
First Report Managed Care
Behind the Bill
Medicare Privatization Under New CMS Leadership: What's Really at Stake
12/11/2024
After writing about Dr Oz's potential impact on Medicare drug negotiations last week, I found myself diving deeper into an aspect of his nomination that deserves closer attention: his vision for Medicare's future. A letter from Senate...
After writing about Dr Oz's potential impact on Medicare drug negotiations last week, I found myself diving deeper into an aspect of his nomination that deserves closer attention: his vision for Medicare's future. A letter from Senate...
After writing about Dr Oz's...
12/11/2024
First Report Managed Care
Behind the Bill
Medicare Drug Negotiations Under New CMS Leadership
12/04/2024
President-elect Donald Trump nominated Dr Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS). With this potential change in leadership, are there any implications for Medicare’s drug price negotiation program,...
President-elect Donald Trump nominated Dr Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS). With this potential change in leadership, are there any implications for Medicare’s drug price negotiation program,...
President-elect Donald Trump...
12/04/2024
First Report Managed Care
Behind the Bill

When Recess Isn’t a Break: What NLRB v Canning Means for HHS
11/20/2024
As Robert F. Kennedy Jr’s nomination for Secretary of Health and Human Services (HHS) moves through the Senate, there’s growing discussion about whether a recess appointment could be used to bypass confirmation challenges. The Supreme Court’s...
As Robert F. Kennedy Jr’s nomination for Secretary of Health and Human Services (HHS) moves through the Senate, there’s growing discussion about whether a recess appointment could be used to bypass confirmation challenges. The Supreme Court’s...
As Robert F. Kennedy Jr’s...
11/20/2024
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use